100557-66-2

Upstream product

• 100557-87-7 Methyl-(Z)-6-<(2-endo,3-exo)-3-carboxybicyclo<2.2.1>hept-2-yl>-5-hexenoat 
• 100557-85-5 Methyl-(Z)-6-<(2-endo,3-endo)-3-(hydroxymethyl)bicyclo<2.2.1>hept-2-yl>-5-hexenoat 
• 100557-83-3 (Z)-6-<(2-endo,3-endo)-3-(Hydroxymethyl)bicyclo<2.2.1>hept-2-yl>-5-hexensaeure 
• 87256-00-6 (1α,3aβ,4β,7β,7aβ)-1,3,3a,4,5,6,7,7a-Octahydro-4,7-methanoisobenzofuran-1-ol 
• 95340-91-3 (+/-)-cis-endo-2,3-bis(hydroxymethyl)bicyclo<2.2.1>heptane-2-carboxylic acid lactone 
• 17814-85-6 (4-carboxybutyl)triphenylphosphonium bromide 
• 100557-56-0 Methyl-(Z)-6-<(2-endo,3-exo)-3-<<2-(3-chlorphenyl)-2-hydroxyethyl>carbamoyl>bicyclo<2.2.1>hept-2-yl>-5-hexenoat 

Relevant academic research and scientific papers

6-(3-Carbamoylbicyclohept-2-yl)hexanoic Acids, a New Class of TxA2 Antagonists

The synthesis of prostanoids 20-27, 40a, b, and 45a, b starting from the educts 1a, b, and 31 is described.Configurational changes concerning to the positions 2 and 3 of the bicyclic system were proofed by 13C-NMR spectroscopy and were also used for the preparation of the four exo/endo derivatives. 25 and 26 are potent TxA2 antagonists.